SLC1A2 and epilepsy: For example, a reduced level of EAAT2 protein expression was detected by immunohistochemical methods in the hippocampus of patients with temporal epilepsy [23], and decreased expression of glutamate transporters was reported in different animal models of epilepsy, including pilocarpine [25], kainite [27], and post-traumatic [26] models.